Compare DPRO & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DPRO | RPID |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 178.6M |
| IPO Year | N/A | 2021 |
| Metric | DPRO | RPID |
|---|---|---|
| Price | $9.51 | $3.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $15.67 | $8.00 |
| AVG Volume (30 Days) | ★ 1.7M | 162.2K |
| Earning Date | 11-12-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,335,758.00 | ★ $30,523,000.00 |
| Revenue This Year | $50.81 | $19.36 |
| Revenue Next Year | $149.77 | $21.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 26.74 | 16.63 |
| 52 Week Low | $1.63 | $1.00 |
| 52 Week High | $14.40 | $4.50 |
| Indicator | DPRO | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 65.21 | 42.57 |
| Support Level | $6.56 | $2.70 |
| Resistance Level | $8.36 | $3.45 |
| Average True Range (ATR) | 0.73 | 0.23 |
| MACD | 0.27 | 0.03 |
| Stochastic Oscillator | 88.05 | 47.56 |
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.